Skip to main content
. 2016 Sep 16;5(9):e004132. doi: 10.1161/JAHA.116.004132

Table 2.

Odds Ratios and 95% Confidence Intervals of Diabetes in Relation to Quintile and Unit Increase in Cumulative Exposure of CVH

Group of Cumulative Exposure of CVH 1 Unit Increase P for Trend
Q1 Q2 Q3 Q4 Q5
Total, n 6864 6865 6864 6866 6864
Case number, n (%) 423 (6.16) 295 (4.30) 266 (3.88) 167 (2.43) 150 (2.19)
Model 1a 1.00 0.64 (0.55–0.74) 0.56 (0.48–0.66) 0.33 (0.28–0.40) 0.28 (0.23–0.35) 0.95 (0.95–0.96) <0.001
Model 2b 1.00 0.63 (0.54–0.74) 0.55 (0.47–0.65) 0.32 (0.27–0.39) 0.28 (0.23–0.34) 0.95 (0.95–0.96) <0.001
Model 3c 1.00 0.69 (0.59–0.81) 0.62 (0.52–0.73) 0.35 (0.28–0.43) 0.32 (0.25–0.40) 0.96 (0.95–0.96) <0.001
Sex
Women 42 (9.88) 47 (5.10) 63 (4.59) 56 (2.54) 67 (1.95)
Model 3c 1.00 0.57 (0.36–0.92) 0.65 (0.41–1.01) 0.39 (0.24–0.62) 0.30 (0.18–0.47) 0.95 (0.94–0.97) <0.001
Men 381 (5.92) 248 (4.17) 203 (3.70) 111 (2.38) 83 (2.42)
Model 3c 1.00 0.71 (0.60–0.84) 0.61 (0.50–0.73) 0.33 (0.26–0.42) 0.35 (0.27–0.46) 0.96 (0.95–0.97) <0.001
P‐interaction 0.311 0.885 0.958 0.218
Age, y
<40  65 (3.86) 39 (2.42) 24 (1.44) 13 (0.73) 12 (0.64)
Model 3c 1.00 0.75 (0.49–1.14) 0.46 (0.28–0.76) 0.22 (0.12–0.43) 0.23 (0.11–0.47) 0.95 (0.93–0.96) <0.001
40 to 59  304 (6.51) 210 (4.75) 187 (4.37) 109 (2.72) 97 (2.58)
Model 3c 1.00 0.75 (0.62–0.91) 0.69 (0.56–0.84) 0.40 (0.31–0.51) 0.37 (0.28–0.49) 0.96 (0.95–0.97) <0.001
P‐interaction 0.572 0.027 0.017 0.021
≥60  54 (10.59) 46 (5.51) 55 (6.00) 45 (4.16) 41 (3.33)
Model 3c 1.00 0.49 (0.32–0.75) 0.57 (0.37–0.86) 0.33 (0.21–0.53) 0.30 (0.18–0.47) 0.96 (0.94–0.98) <0.001
P‐interaction 0.345 0.209 0.101 0.143
Sensitivity analysis
Model 4d 1.00 0.69 (0.59–0.82) 0.63 (0.53–0.74) 0.35 (0.28–0.43) 0.32 (0.26–0.40) 0.96 (0.95–0.97) <0.001

CVH indicates ideal cardiovascular health; Q1, quintile 1; Q2, quintile 2; Q3, quintile 3; Q4, quintile 4; Q5, quintile 5.

a

Adjusted for age (years), sex.

b

Adjusted for as Model 1 plus education level (elementary school, high school, or college or above), income level (income ≥ ¥800/month, ¥600 to ¥800/month, and < ¥600/month), and drinking (never, past, current <1 times/day or current 1+times/day).

c

Adjusted for as model 2 plus high‐sensitivity C‐reactive protein, uric acid, resting heart rate at Exam 1 and medication usage before Exam 4.

d

Adjusted for Model 3 and further excluded individuals with cardiovascular disease (myocardial infarction) before Exam 4.